Drug Combination Details
| General Information of the Combination (ID: C52446) | |||||
|---|---|---|---|---|---|
| Name | Streptozocin | + | 5-fluorouracil + Doxorubicin | ||
| Click to Show/Hide the Each NP or Drug Information of This Combination | |||||
| Name | Streptozocin NP Info | Drug Info | |||
| Structure |
|
|
|||
| Name | Drug Info | ||||
| Structure |
|
|
|||
| Disease |
Pancreatic endocrine tumor
[ICD-11: 2E92]
|
Phase 2 | [1] | ||
|
Pancreatic cancer
[ICD-11: 2C10]
|
Investigative | [2] | |||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. Decreasing Adverse Drug Reaction by This Combination | ||||||
| Decreasing Adverse Drug Reaction | Click to Show/Hide | |||||
| Experiment 1 Reporting the Effect of This Combination | [2] | |||||
| In-vivo Model | Clinical trial | |||||
| Experimental
Result(s) |
The use of FAS before liver resection is associated with improved OS compared with surgery alone among patients with advanced synchronous pancreatic neuroendocrine liver metastases. | |||||
